Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Covidien medtech sales grow during fiscal Q3

This article was originally published in Clinica

Executive Summary

Covidien (Dublin, Ireland) witnessed steady growth from its largest business division, medical devices, during the third fiscal quarter, with its oximetry and energy devices units putting in strong performances. Total medical device revenue for the period, was $1.63bn, a 6% improvement on Q3 2009. Covidien’s endomechanical (+4% to $533m), energy devices (+14% to $252m), oximetry and monitoring products (+22% to $189m) and vascular (+22% to $175m) businesses all showed solid growth, though sales of the company’s soft tissue repair products were flat at $209m. Second-quarter revenue from the firm’s airway and ventilation products fell by 6% to $178m because of lower sales of sleep products following the divestiture of Covidien’s sleep diagnostics product line to Embla in 2009 (www.clinica.co.uk, 4 September 2009). The firm’s medical device business excelled compared to its pharmaceutical revenues, which fell by 6%. Covidien's third division, medical supplies, also saw sales dip 3% to $439m. Overall, group sales went up 2% to $2.56bn.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT095284

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel